HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results

114
8
Favorite

HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results

Reuters2021-08-24

** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains

** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index

** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan

** Brokerage Daiwa reaffirms "buy" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth

** The Hong Kong Hang Seng Commerce & Industry Index surges 2.7% and the healthcare index jumps 3.1%

** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%

** As of last close, stock had risen 9.9% this year

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

114

Report

Comment（8）

Colin08
·2021-08-24
Bio stock is usually safe to buy
Reply
6
Report
yeelyn18
·2021-08-24
Cool
Reply
3
Report
Fold Replies
- yeelyn18:
  Nice
  2021-08-24
  Reply
  Report
Jaymand
·2021-08-24
Like pls
Reply
5
Report
Fold Replies
- Desmond669:
  Ok
  2021-08-24
  Reply
  Report
- jerminos:
  Done!
  2021-08-24
  Reply
  Report
Jayne seah
·2021-08-24
Ok
Reply
6
Report
Fold Replies
- Milankaka:
  Ok
  2021-08-24
  Reply
  Report
chongyeetan
·2021-08-24
pls like. ?
Reply
6
Report
Fold Replies
- szueyann:
  ok
  2021-08-24
  Reply
  Report
Heidit
·2021-08-24
Cool
Reply
6
Report
Fold Replies
- Joker_Smile:
  ?
  2021-08-24
  Reply
  Report
Tj23
·2021-08-24
Please like
Reply
7
Report
Fold Replies
- szueyann:
  ok
  2021-08-24
  Reply
  Report
balaranjith
·2021-08-24
Nice
Reply
8
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2161035687?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-08-24 09:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2161035687","market":"hk","top_or_hot":-1,"title":"HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results","media":"Reuters","content":"<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK-listed WuXi Biologics rises most in 4 weeks after strong H1 results\n</h2>\n\n<h4 class=\"meta\">\n\n2021-08-24 09:53 北京时间&nbsp;&nbsp;&nbsp;<strong>Reuters</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains\n** Stock hits the highest level ...</p>\n\n<a href=\"None\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02269","symbol_name":"药明生物","start_time":0,"source_url":null,"article_id":"2161035687","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2161035687","pubTimestamp":1629769998,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02269":"药明生物"},"translate_title":"香港上市无锡生物制品4周涨幅最大H1业绩强劲","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02269":0.9},"content_text":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains\n** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index\n** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan\n** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth\n** The Hong Kong Hang Seng Commerce & Industry Index surges 2.7% and the healthcare index jumps 3.1%\n** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%\n** As of last close, stock had risen 9.9% this year","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":834378491,"gmtCreate":1629775667013,"gmtModify":1676530127744,"author":{"id":"4087627628112160","authorId":"4087627628112160","name":"Colin08","avatar":"https://static.tigerbbs.com/ab590c79f18062df60b11029eea8083d","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4087627628112160","idStr":"4087627628112160"},"htmlText":"Bio stock is usually safe to buy","listText":"Bio stock is usually safe to buy","text":"Bio stock is usually safe to buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/834378491","repostId":2161035687,"repostType":4,"repost":{"id":"2161035687","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629769998,"share":"https://ttm.financial/m/news/2161035687?lang=&edition=fundamental","pubTime":"2021-08-24 09:53","market":"hk","language":"en","title":"HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2161035687","media":"Reuters","summary":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest ","content":"<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK-listed WuXi Biologics rises most in 4 weeks after strong H1 results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-24 09:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02269":"药明生物"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161035687","content_text":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains\n** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index\n** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan\n** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth\n** The Hong Kong Hang Seng Commerce & Industry Index surges 2.7% and the healthcare index jumps 3.1%\n** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%\n** As of last close, stock had risen 9.9% this year","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":834327111,"gmtCreate":1629773678633,"gmtModify":1676530127071,"author":{"id":"3574914526090483","authorId":"3574914526090483","name":"yeelyn18","avatar":"https://static.tigerbbs.com/ae47c3e96729c68a0234dd22850dfe69","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3574914526090483","idStr":"3574914526090483"},"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/834327111","repostId":2161035687,"repostType":4,"repost":{"id":"2161035687","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629769998,"share":"https://ttm.financial/m/news/2161035687?lang=&edition=fundamental","pubTime":"2021-08-24 09:53","market":"hk","language":"en","title":"HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2161035687","media":"Reuters","summary":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest ","content":"<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK-listed WuXi Biologics rises most in 4 weeks after strong H1 results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-24 09:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02269":"药明生物"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161035687","content_text":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains\n** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index\n** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan\n** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth\n** The Hong Kong Hang Seng Commerce & Industry Index surges 2.7% and the healthcare index jumps 3.1%\n** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%\n** As of last close, stock had risen 9.9% this year","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5629093,"gmtCreate":1629773707888,"gmtModify":1663232826929,"authorId":3574914526090483,"author":{"id":3574914526090483,"idStr":"3574914526090483","authorId":3574914526090483,"name":"yeelyn18","avatar":"https://static.tigerbbs.com/ae47c3e96729c68a0234dd22850dfe69","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":834327111,"type":1,"supId":0,"prevId":0,"content":"Nice","text":"Nice","html":"Nice"}],"langContent":"EN"},{"id":834319370,"gmtCreate":1629771383690,"gmtModify":1676530126040,"author":{"id":"3564142991914856","authorId":"3564142991914856","name":"Jaymand","avatar":"https://static.tigerbbs.com/e2ef74d005aec91c36d540483cb5d0f1","vip":1,"hat":"https://static.tigerbbs.com/7b75ce0c34afff716602792a5d0929dd","crmLevel":4,"crmLevelSwitch":1,"authorIdStr":"3564142991914856","idStr":"3564142991914856"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/834319370","repostId":2161035687,"repostType":4,"repost":{"id":"2161035687","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629769998,"share":"https://ttm.financial/m/news/2161035687?lang=&edition=fundamental","pubTime":"2021-08-24 09:53","market":"hk","language":"en","title":"HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2161035687","media":"Reuters","summary":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest ","content":"<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK-listed WuXi Biologics rises most in 4 weeks after strong H1 results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-24 09:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02269":"药明生物"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161035687","content_text":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains\n** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index\n** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan\n** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth\n** The Hong Kong Hang Seng Commerce & Industry Index surges 2.7% and the healthcare index jumps 3.1%\n** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%\n** As of last close, stock had risen 9.9% this year","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5628851,"gmtCreate":1629772201405,"gmtModify":1663232828927,"authorId":3562118563279867,"author":{"id":3562118563279867,"idStr":"3562118563279867","authorId":3562118563279867,"name":"Desmond669","avatar":"https://static.tigerbbs.com/e2484115c94d3471cb46f20ea7598b4a","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.05.31","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":834319370,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":5628693,"gmtCreate":1629771405756,"gmtModify":1663232824347,"authorId":3583841475339760,"author":{"id":3583841475339760,"idStr":"3583841475339760","authorId":3583841475339760,"name":"jerminos","avatar":"https://static.tigerbbs.com/4b6b79d65a5ecd18fecf889c39f99b14","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":834319370,"type":1,"supId":0,"prevId":0,"content":"Done!","text":"Done!","html":"Done!"}],"langContent":"EN"},{"id":834337824,"gmtCreate":1629771295768,"gmtModify":1676530125927,"author":{"id":"3573725828950874","authorId":"3573725828950874","name":"Jayne seah","avatar":"https://static.tigerbbs.com/89e79cc9d213c3487de87f1ced1f5b01","vip":1,"crmLevel":7,"crmLevelSwitch":1,"authorIdStr":"3573725828950874","idStr":"3573725828950874"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/834337824","repostId":2161035687,"repostType":4,"repost":{"id":"2161035687","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629769998,"share":"https://ttm.financial/m/news/2161035687?lang=&edition=fundamental","pubTime":"2021-08-24 09:53","market":"hk","language":"en","title":"HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2161035687","media":"Reuters","summary":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest ","content":"<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK-listed WuXi Biologics rises most in 4 weeks after strong H1 results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-24 09:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02269":"药明生物"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161035687","content_text":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains\n** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index\n** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan\n** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth\n** The Hong Kong Hang Seng Commerce & Industry Index surges 2.7% and the healthcare index jumps 3.1%\n** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%\n** As of last close, stock had risen 9.9% this year","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5628781,"gmtCreate":1629771842654,"gmtModify":1663232825272,"authorId":3579096500575753,"author":{"id":3579096500575753,"idStr":"3579096500575753","authorId":3579096500575753,"name":"Milankaka","avatar":"https://static.tigerbbs.com/288ce834db4366c3536976047323d1ce","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":834337824,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":834338556,"gmtCreate":1629771024675,"gmtModify":1676530125828,"author":{"id":"3573519539005968","authorId":"3573519539005968","name":"chongyeetan","avatar":"https://static.tigerbbs.com/58f6eb6730af7768ad82093944f2351a","vip":1,"hat":"https://static.tigerbbs.com/6444b4970948c1077534c593eccd6d16","crmLevel":6,"crmLevelSwitch":1,"authorIdStr":"3573519539005968","idStr":"3573519539005968"},"htmlText":"pls like. ?","listText":"pls like. ?","text":"pls like. ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/834338556","repostId":2161035687,"repostType":4,"repost":{"id":"2161035687","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629769998,"share":"https://ttm.financial/m/news/2161035687?lang=&edition=fundamental","pubTime":"2021-08-24 09:53","market":"hk","language":"en","title":"HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2161035687","media":"Reuters","summary":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest ","content":"<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK-listed WuXi Biologics rises most in 4 weeks after strong H1 results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-24 09:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02269":"药明生物"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161035687","content_text":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains\n** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index\n** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan\n** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth\n** The Hong Kong Hang Seng Commerce & Industry Index surges 2.7% and the healthcare index jumps 3.1%\n** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%\n** As of last close, stock had risen 9.9% this year","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5628664,"gmtCreate":1629771297300,"gmtModify":1631893987692,"authorId":3573721781255613,"author":{"id":3573721781255613,"idStr":"3573721781255613","authorId":3573721781255613,"name":"szueyann","avatar":"https://static.tigerbbs.com/cba9c6b1e785a9cf7301a7e6a2ff2354","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":834338556,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"},{"id":834394809,"gmtCreate":1629770668501,"gmtModify":1676530125682,"author":{"id":"3585567341976837","authorId":"3585567341976837","name":"Heidit","avatar":"https://static.tigerbbs.com/b15a14bcb1e7c71684448d84f3e500e7","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3585567341976837","idStr":"3585567341976837"},"htmlText":"Cool&nbsp;","listText":"Cool&nbsp;","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/834394809","repostId":2161035687,"repostType":4,"repost":{"id":"2161035687","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629769998,"share":"https://ttm.financial/m/news/2161035687?lang=&edition=fundamental","pubTime":"2021-08-24 09:53","market":"hk","language":"en","title":"HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2161035687","media":"Reuters","summary":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest ","content":"<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK-listed WuXi Biologics rises most in 4 weeks after strong H1 results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-24 09:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02269":"药明生物"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161035687","content_text":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains\n** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index\n** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan\n** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth\n** The Hong Kong Hang Seng Commerce & Industry Index surges 2.7% and the healthcare index jumps 3.1%\n** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%\n** As of last close, stock had risen 9.9% this year","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5628837,"gmtCreate":1629772125020,"gmtModify":1663232825445,"authorId":3574572092080891,"author":{"id":3574572092080891,"idStr":"3574572092080891","authorId":3574572092080891,"name":"Joker_Smile","avatar":"https://static.tigerbbs.com/fb5bf41aabce75edc01766ad80e2bf49","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":834394809,"type":1,"supId":0,"prevId":0,"content":"?","text":"?","html":"?"}],"langContent":"EN"},{"id":834392091,"gmtCreate":1629770543913,"gmtModify":1676530125632,"author":{"id":"3571780042589602","authorId":"3571780042589602","name":"Tj23","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3571780042589602","idStr":"3571780042589602"},"htmlText":"Please like&nbsp;","listText":"Please like&nbsp;","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/834392091","repostId":2161035687,"repostType":4,"repost":{"id":"2161035687","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629769998,"share":"https://ttm.financial/m/news/2161035687?lang=&edition=fundamental","pubTime":"2021-08-24 09:53","market":"hk","language":"en","title":"HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2161035687","media":"Reuters","summary":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest ","content":"<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK-listed WuXi Biologics rises most in 4 weeks after strong H1 results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-24 09:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02269":"药明生物"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161035687","content_text":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains\n** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index\n** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan\n** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth\n** The Hong Kong Hang Seng Commerce & Industry Index surges 2.7% and the healthcare index jumps 3.1%\n** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%\n** As of last close, stock had risen 9.9% this year","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5628663,"gmtCreate":1629771292015,"gmtModify":1663232824449,"authorId":3573721781255613,"author":{"id":3573721781255613,"idStr":"3573721781255613","authorId":3573721781255613,"name":"szueyann","avatar":"https://static.tigerbbs.com/cba9c6b1e785a9cf7301a7e6a2ff2354","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":834392091,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"},{"id":834393098,"gmtCreate":1629770380914,"gmtModify":1676530125539,"author":{"id":"3584866490611464","authorId":"3584866490611464","name":"balaranjith","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3584866490611464","idStr":"3584866490611464"},"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/834393098","repostId":2161035687,"repostType":4,"repost":{"id":"2161035687","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629769998,"share":"https://ttm.financial/m/news/2161035687?lang=&edition=fundamental","pubTime":"2021-08-24 09:53","market":"hk","language":"en","title":"HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2161035687","media":"Reuters","summary":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest ","content":"<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK-listed WuXi Biologics rises most in 4 weeks after strong H1 results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK-listed WuXi Biologics rises most in 4 weeks after strong H1 results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-24 09:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains</p>\n<p>** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index</p>\n<p>** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan</p>\n<p>** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth</p>\n<p>** The Hong Kong Hang Seng Commerce &amp; Industry Index surges 2.7% and the healthcare index jumps 3.1%</p>\n<p>** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%</p>\n<p>** As of last close, stock had risen 9.9% this year</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02269":"药明生物"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161035687","content_text":"** Shares of WuXi Biologics (Cayman) Inc climb as much as 9.7% to HK$124, heading for their biggest daily pct rise since July 28 and a second straight session of gains\n** Stock hits the highest level since Aug. 13; second-biggest pct gainer on the benchmark Hang Seng Index\n** Jiangsu, China-based co says H1 net profit jumped 163% to 1.77 bln yuan ($273.1 mln) with revenue surging 126.7% to 4.41 bln yuan\n** Brokerage Daiwa reaffirms \"buy\" rating, saying its revenue growth was a solid beat and growing number of projects provides a solid ground for its long-term growth\n** The Hong Kong Hang Seng Commerce & Industry Index surges 2.7% and the healthcare index jumps 3.1%\n** The Hang Seng China Enterprises Index rises 1.6%, and the benchmark index climbs 1.2%\n** As of last close, stock had risen 9.9% this year","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":114,"commentSize":8,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}